Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial

PaperCitations, authors & open-access status

Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 357 citations, 2019 year and closed oa status.

357
Citations
2019
Year
closed
OA Status

Related on ScholarIQ

Alice T. Shaw
Author
Benjamin Besse
Author
Ross A. Soo
Author
Benjamin Solomon
Author
Gregory J. Riely
Author
The Lancet Oncology
Journal
470M+ articles · free account